EQUINE MEDIRECORD UK LIMITED

Company Registration Number:
11489072 (England and Wales)

Unaudited abridged accounts for the year ended 31 December 2024

Period of accounts

Start date: 01 January 2024

End date: 31 December 2024

EQUINE MEDIRECORD UK LIMITED

Contents of the Financial Statements

for the Period Ended 31 December 2024

Balance sheet
Notes

EQUINE MEDIRECORD UK LIMITED

Balance sheet

As at 31 December 2024


Notes
2024
2023


£
£
Called up share capital not paid: 0 0
Fixed assets
Intangible assets:   0 0
Tangible assets: 3 0 150
Investments:   0 0
Total fixed assets: 0 150
Current assets
Stocks: 0 0
Debtors: 4 720 3,901
Cash at bank and in hand: 1,661 5,789
Investments:   0 0
Total current assets: 2,381 9,690
Creditors: amounts falling due within one year:   (123,488) (58,457)
Net current assets (liabilities): (121,107) (48,767)
Total assets less current liabilities: (121,107) (48,617)
Creditors: amounts falling due after more than one year:   0 0
Provision for liabilities: 0 0
Total net assets (liabilities): (121,107) (48,617)
Capital and reserves
Called up share capital: 100 100
Share premium account: 0 0
Revaluation reserve: 00
Other reserves: 0 0
Profit and loss account: (121,207) (48,717)
Shareholders funds: (121,107) (48,617)

The notes form part of these financial statements

EQUINE MEDIRECORD UK LIMITED

Balance sheet statements

For the year ending 31 December 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 29 September 2025
and signed on behalf of the board by:

Name: FINLAY O'ROURKE DARGAN
Status: Director

The notes form part of these financial statements

EQUINE MEDIRECORD UK LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2024

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

EQUINE MEDIRECORD UK LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2024

2. Employees

2024 2023
Average number of employees during the period 1 1

EQUINE MEDIRECORD UK LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2024

3. Tangible Assets

Total
Cost £
At 01 January 2024 2,998
Additions 0
Disposals 0
Revaluations 0
Transfers 0
At 31 December 2024 2,998
Depreciation
At 01 January 2024 2,848
Charge for year 150
On disposals 0
Other adjustments 0
At 31 December 2024 2,998
Net book value
At 31 December 2024 0
At 31 December 2023 150

EQUINE MEDIRECORD UK LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2024

4. Debtors

2024 2023
££
Debtors due after more than one year: 0 0

EQUINE MEDIRECORD UK LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2024

5. Related party transactions

Name of the related party:
Relationship:
Common Director and Shareholder
Description of the Transaction: The transaction was to assist with cashflow.
£
Balance at 01 January 2024 23,054
Balance at 31 December 2024 68,490